Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 3
2005 2
2006 8
2007 6
2008 8
2009 6
2010 15
2011 24
2012 28
2013 39
2014 38
2015 62
2016 62
2017 52
2018 42
2019 43
2020 41
2021 51
2022 38
2023 54
2024 29

Text availability

Article attribute

Article type

Publication date

Search Results

528 results

Results by year

Filters applied: . Clear all
Page 1
Pragmatic nationwide master observational trial based on genomic alterations in advanced solid tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS)-II study protocol KCSG AL-22-09.
Kim SY, Kim JH, Kim TY, Park SR, Yoon S, Lee S, Lee SH, Kim TM, Han SW, Kim HR, Yun H, Lee S, Kim J, Choi YL, Choi KS, Chae H, Ryu H, Lee GW, Zang DY, Ahn JB. Kim SY, et al. Among authors: kim tm. BMC Cancer. 2024 May 9;24(1):574. doi: 10.1186/s12885-024-12338-y. BMC Cancer. 2024. PMID: 38724991 Free PMC article.
Histological transformation to small-cell carcinoma.
Oh S, Kim TM. Oh S, et al. Among authors: kim tm. Nat Rev Cancer. 2024 May 2. doi: 10.1038/s41568-024-00697-4. Online ahead of print. Nat Rev Cancer. 2024. PMID: 38698127 No abstract available.
ASCT2-Targeting Antibody-Drug Conjugate MEDI7247 in Adult Patients with Relapsed/Refractory Hematological Malignancies: A First-in-Human, Phase 1 Study.
Maris M, Salles G, Kim WS, Kim TM, Lyons RM, Arellano M, Karmali R, Schiller G, Cull E, Abboud CN, Batlevi C, Kagiampakis I, Rebelatto MC, Lee Y, Kirby LC, Wang F, Bothos J, Townsley DM, Fathi AT, Ribrag V. Maris M, et al. Among authors: kim tm. Target Oncol. 2024 Apr 29. doi: 10.1007/s11523-024-01054-z. Online ahead of print. Target Oncol. 2024. PMID: 38683495
528 results